Scientists test new smallpox shot on unvaccinated adults

NCT ID NCT00437021

Summary

This study tested a new smallpox vaccine called IMVAMUNE to see how safe it was and how well it triggered the body's immune defenses. It involved 226 healthy adults who had never received a smallpox vaccine. Researchers compared different dosing schedules, giving some people one shot and others two shots, to find the best way to build protection.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMALLPOX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Case Western Reserve University - John T. Carey Special Immunology Unit

    Cleveland, Ohio, 44106-3808, United States

  • Duke Translational Medicine Institute - Clinical Vaccine Unit

    Durham, North Carolina, 27704-2120, United States

  • Saint Louis University Center for Vaccine Development

    St Louis, Missouri, 63104-1015, United States

  • University of Iowa - Vaccine Research and Education Unit

    Iowa City, Iowa, 52242-2600, United States

  • University of Maryland, School of Medicine, Center for Vaccine Development and Global Health

    Baltimore, Maryland, 21201-1509, United States

  • University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases

    Rochester, New York, 14642-0001, United States

  • University of Texas Medical Branch - Pediatrics - Infectious Diseases and Immunology - Galveston

    Galveston, Texas, 77555-5302, United States

Conditions

Explore the condition pages connected to this study.